1Luger TA, Scholzen TE, Brzoska T and B6hm M. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann N Y Aead Sci 2003, 994: 133-140.
2Maaser C, Kannengiesser K and Kucharzik T. Role of the melanocortin system in inflammation. Ann N Y Acad Sci 2006, 1072: 123-134.
3Brzoska T, Luger TA, Maaser C, Abels C and Bohm M. alphamelanocyte-stimulating hormone and related tripeptides: Biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 2008, 29:581-602.
4Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T and Luger TA. Pro-opiomelanocortin-derived pePtides induce IL-10 production in human monocytes. J Immunol 1996, 156: 2517-21.
5Star RA, Rajora N, Huang J, Stock RC, Catania A and Lipton JM. Evidence of autocrine modulation of macrophage nitric-oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 1995, 92: 8016-8020.
6Becher E, Mahnke K, Brzoska T, Kalden DH, Grabbe S and Luger TA. Human peripheral blood-derived dendritic cells express functional melano- cortin receptor MC-1R. Ann N Y Acad Sci 1999, 885: 188-195.
7Gatti S, Colombo G, Buffa R, Turcatti F, Garofalo L, Carboni N and Ferla L, et al. a-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 2002, 74:1678-1684.
8Luger TA and Brzoska T. α-MSH related peptides: a new class of antiinflammatory and immunomodulating drugs. Ann Rheum Dis 2007, 3 (Suppl): 52-55.
9Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ and Pulendran B, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18: 767-811.
10Steinman RM, Hawiger D and Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003, 21:685-711.
2Karaagac K, Yontar OC, Tenekecioglu E,et al. Evaluation of Tp-Te interval and Tp - Te/QTc ratio in patients with coronary ar-tery ectasia[Jj. Int J Clin Exp Med,2014 ,7(9) : 2865 - 2870.
3Sultana R,Sultana N,Ishaq M, et al. The prevalence and clinicalprofile of angiographic coronary ectasia [ J ]. J Pak Med Assoc,2011,61(4) :372 -375.
4Nakamura K,Sakurai M, Miura K,et al. Homeostasis model as-sessment of insulin resistance and the risk of cardiovascular eventsin middle - aged non - diabetic Japanese men [ J ]. Diabetologia,2010,53(9):1894 -1902.
5Armato J,Defronzo RA, Abdul - Ghani M. Successful Treatment ofPrediabetes in Clinical Practice : Targeting Insulin Resistance andBeta Cell Dysfunction [ J]. Endocr Pract,2011 ,8(1):1 - 21.
7Soto ME,Reyes-Villatoro MA,Mdrquez R,et al. Evaluation and a-nalysis of plasma soluble adhesion molecules in patients with coro-nary ectasia and atherosclerotic coronary artery disease [ J ]. ArchMed Res,2014,45(6) :478 -483.
8Farrag A, Faramawy AE, Salem MA, et al. Coronary artery ectasiadiagnosed using multidetector computed tomography : morphologyand relation to coronary artery calcification [ J ]. Int J CardiovascImaging,2013,29(2) :427 -433.
9Hamirani YS, Nasir K, Avanes E, et al. Coronary artery diameterrelated to calcium scores and coronary risk factors as measuredwith multidetector computed tomography : a substudy of the ACCU-RACY trial[J].Tex Heart Inst J,2013,40(3) :261 -267.
